Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PIMAVANSERIN vs PIMOZIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PIMAVANSERIN vs PIMOZIDE: Safety Overview

Metric PIMAVANSERIN PIMOZIDE
Total FAERS Reports 46,338 257
Deaths Reported 12,352 56
Death Rate 26.7% 21.8%
Hospitalizations 7,471 90
Average Patient Age 76.5 yrs 36.0 yrs
% Female Patients 38.7% 39.5%
FDA Approval Date Apr 29, 2016 Aug 27, 1997
Manufacturer Novadoz Pharmaceuticals LLC Endo USA, Inc.
Route ORAL ORAL
Marketing Status Discontinued Discontinued